Oct 22, 2025 · Herceptin (chemical name: trastuzumab) is a HER2 inhibitor targeted therapy. Herceptin works against HER2-positive breast cancers by blocking the ability of the cancer cells to receive …

Apr 14, 2024 · Find out all you need to know about Herceptin (trastuzumab) for early and more advanced HER2-positive breast cancer, including what to expect, outcomes, side effects, and more.

Mar 3, 2025 · These breast cancers can be treated with HER2-targeted therapies. Trastuzumab (Herceptin) How does trastuzumab work? Trastuzumab is an antibody drug specially made to target …

Aug 10, 2021 · Targeted drug therapy uses medicines that are directed at (target) proteins on breast cancer cells that help them grow, spread, and live longer. Targeted drugs work to destroy cancer …

Trastuzumab (brand name: Herceptin) is a targeted therapy known as a monoclonal antibody, a modified version of an immune system protein, that can attach to proteins on HER2-positive breast …

Trastuzumab (Herceptin) is a targeted therapy for treating breast cancer. Find out when it's used, how it works and possible side effects.

Oct 18, 2023 · 25 years of Herceptin: A groundbreaking advancement in breast cancer treatment This year marks the 25th anniversary of the FDA approval of the first gene-based drug for cancer, which …

Learn about Herceptin® (trastuzumab), a targeted therapy approved for the treatment of HER2+ early breast cancer. See full safety & Boxed Warnings for more information.

Nov 7, 2024 · Introduced as a treatment option more than 25 years ago, this targeted therapy for breast cancer has greatly improved the survival rates and lowered the rates of recurrence for women with …

Apr 17, 2025 · Learn how targeted therapies, including monoclonal antibodies (such as Herceptin or Trastuzumab), can be used to treat breast cancer.